IL10 and diabetes mellitus: Injection of IL-10 alone did not protect NOD mice from diabetes which might indicate that rapamycin first needs to reduce effector T cell proliferation before IL-10 is able to maintain a stable Tr1 cell population, as illustrated by a synergistic effect of rapamycin and IL-10 treatment.